REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $170 | -0.6% | 8,503 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $171 | -28.5% | 9,046 | -14.0% | 0.00% | -50.0% |
| Q4 2022 | $239 | -99.9% | 10,524 | -20.0% | 0.00% | -33.3% |
| Q3 2022 | $348,000 | +23.8% | 13,157 | +15.7% | 0.00% | +50.0% |
| Q2 2022 | $281,000 | -46.4% | 11,368 | -28.0% | 0.00% | -33.3% |
| Q1 2022 | $524,000 | -2.2% | 15,786 | -3.7% | 0.00% | 0.0% |
| Q4 2021 | $536,000 | +92.8% | 16,388 | +147.5% | 0.00% | +50.0% |
| Q3 2021 | $278,000 | -3.1% | 6,622 | -10.4% | 0.00% | 0.0% |
| Q2 2021 | $287,000 | -9.2% | 7,387 | -20.3% | 0.00% | 0.0% |
| Q1 2021 | $316,000 | -63.7% | 9,266 | -51.7% | 0.00% | -71.4% |
| Q4 2020 | $870,000 | +212.9% | 19,180 | +62.4% | 0.01% | +133.3% |
| Q3 2020 | $278,000 | -3.1% | 11,810 | +784.0% | 0.00% | 0.0% |
| Q2 2020 | $287,000 | -9.2% | 1,336 | -86.3% | 0.00% | -57.1% |
| Q1 2020 | $316,000 | – | 9,782 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |